As the numbers of cases of COVID-19 continue to rise, the heterogeneity of its clinical manifestation continues to increase. Here, we describe a case of delayed-onset, biopsy-proven necrotizing myositis following infection with SARS-CoV-2.
Learning points: SARS-CoV-2 may be associated with late-onset necrotizing myositis, mimicking autoimmune inflammatory myositis.We need more studies to understand the underlying pathogenesis of SARS-CoV-2-induced myositis.
Keywords: COVID-19; SARS-CoV-2; necrotizing autoimmune myositis.
© EFIM 2021.